0
Synaptogenix, Inc. Banner Image

Synaptogenix, Inc.

  • Ticker SNPX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Synaptogenix, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. Synaptogenix is led by an experienced team with deep expertise in neurodegenerative disorders and successful track records in both drug discovery and development. Their experience and passion for novel drug therapies have enabled them to developMore a pipeline that includes synaptogenic treatment approaches for serious and difficult-to-treat diseases such as Alzheimer’s disease, Fragile X Syndrome, MS, Parkinsons, Traumatic Brain Injury, Stroke, and Autism Spectrum Disorders.
REPORT RATINGS
4.8 / 5.0 (76)

Synaptogenix, Inc. reports have an aggregate usefulness score of 4.8 based on 76 reviews.

Synaptogenix, Inc.

Most Recent Annual Report

Synaptogenix, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Synaptogenix, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!